Uripan XR tablets 10 mg

Uripan XR tablets are an advanced medication specifically designed to provide sustained relief and effective control of the bothersome symptoms associated with overactive bladder (OAB). This medication contains the active ingredient oxybutynin 10 mg, but in a unique extended-release (XR) formulation. This innovative technology allows the medication to be released slowly and steadily throughout the day, minimizing fluctuations in blood levels, contributing to a sustained therapeutic effect, and reducing the potential for some of the side effects associated with immediate-release formulations. Uripan XR is an important treatment option for individuals with OAB, significantly improving their quality of life by reducing the frequent and sudden need to urinate and urge incontinence.

The active ingredient in Uripan XR tablets

Each Uripan XR tablet contains the following active ingredient, responsible for its therapeutic effect in treating OAB:

Oxybutynin: 10 mg This strength is effective in controlling the symptoms of overactive bladder (OAB) in many adult patients. The extended-release formulation ensures gradual drug release over 24 hours.

Available Strengths

Uripan XR tablets are typically available in the following strengths:

Oxybutynin: 10 mg (extended-release formulation).

Other strengths of oxybutynin may be available in extended-release or immediate-release formulations, such as 5 mg, to meet different patient needs based on the severity of symptoms and response to treatment. The physician determines the appropriate strength and dosage form based on a clinical assessment of each individual case.

Indications for Use of Uripan XR Tablets

Uripan XR tablets are primarily used to treat symptoms associated with overactive bladder (OAB), which include:

Urinary Frequency: The need to urinate more than 8 times during the day or more than twice during the night.

Urinary Urgency: A sudden, strong feeling of needing to urinate that is difficult to delay. Urge urinary incontinence: Involuntary loss of urine accompanied or preceded by a sudden, urgent need to urinate.